Curcugen® Curcumin Formulation Attains GRAS status

Our Bureau

CURCUGEN®, DolCas Biotech’s bioavailability-enhanced, water-dispersible curcuminoid complex, has received Self-Affirmed Generally Recognized As Safe (GRAS) status. This designation was unanimously accorded by an independent panel of scientific experts and based on scientific procedures, concluding that CURCUGEN meets FDA’s definition of safety when used as an ingredient in yogurt, nutrition bars, […]

New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment

Our Bureau

Novartis today announced new data that reinforce the transformational benefit of Zolgensma® (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular atrophy (SMA). The overall safety profile remains favorable following presymptomatic treatment, in the long-term follow-up period from clinical studies and in the real-world setting. These data were presented during the 2021 […]

Calliditas Announces Submission of New Drug Application to U.S. FDA for Nefecon in Patients with Primary IgA Nephropathy

Our Bureau

Calliditas Therapeutics AB (NASDAQ: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Nefecon, a novel oral formulation targeting down regulation of IgA1 for the treatment of primary IgA Nephropathy (IgAN). Calliditas is seeking accelerated […]

Manipal Hospitals Conducts Free Covid-19 Vaccination For All Their Dialysis Patients On World Kidney Day

Our Bureau

On the account of World Kidney Day observed on 11th March, Manipal Hospitals has undertaken a new initiative to provide Covid-19 vaccination free-of-cost for those patients undergoing dialysis at Manipal Hospitals. The vaccinations were offered across all Manipal Hospital centers at Old Airport Road, Whitefield, and Malleshwaram. Kidney patients are at […]

Precision Oncology start-up 4baseCare raises $ 2m in pre-series A round from a consortium of venture capital firms

Our Bureau

4baseCare, an Illumina Accelerator backed precision oncology start-up, has raised an investment of USD 2M, led by investors Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures and a few strategic angel investors. The investor group has a strong understanding of healthcare & technology and focuses on creating social impact through […]

BITE Bispecific Antibody Drug Market Size Sales Clinical Trials Development Report 2025

Our Bureau

“Global BiTE Antibodies Market, Price, Sales & Clinical Trials Insight 2025” Report Highlights: Global BiTE Antibody Market Opportunity Insight (2021-2025) Currently Only 1 BiTE Commercially Available In Market: Blinatumomab (Blincyto) Blincyto Dosage & Market Sales Analysis ( Yearly, Quarterly & Regional Sales) Global BiTE Antibody Clinical Trials Indicators by Phase, Company, […]

Subscribe Now